What question did this study set out to answer?

To describe a unique pattern of cutaneous immune-related adverse events triggered by pembrolizumab.

April 24, 2026The Journal of Dermatology0 citations

Unilateral Mosaic Pattern of Cutaneous Immune‐Related Adverse Event Induced by Pembrolizumab: A Case Report

KTKazumori TakamotoKyoto Medical Center KGK. GotoKyoto University KNKosei NishitaniKyoto Medical Center

Key Points

To describe a unique pattern of cutaneous immune-related adverse events triggered by pembrolizumab.
Detailed case report of a patient experiencing specific skin reactions to pembrolizumab.
Clinical observations and photographic documentation of the skin manifestations.
The patient exhibited a unilateral mosaic pattern of skin changes.
The adverse events were associated with pembrolizumab treatment, diverging from typical presentations.

Abstract

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

问 AI

Bookmark

View Full Paper